post-thrombotic syndrome, PTS, May-Thurner syndrome, MTS, venous claudication, outflow obstruction, deep venous obstruction, stenting, stent, deep venous thrombosis, DVT
Conditions
Interventions
PTA & stenting.
Sponsors
Maastricht University Medical Centre+
Eligibility
Inclusion criteria
Inclusion criteria: 1. Indication for stenting; 2. Minimally 18 years of age; 3. Life expectancy of at least 6 months.
Exclusion criteria
Exclusion criteria: 1. Younger than 18 years of age; 2. Life expectancy of less than 6 months; 3. Venous obstruction in the contralateral limb; 4. Peripheral arterial disease; 5. Pregnancy.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| There are various secondary endpoints. Change in pain free walking distance and maximum walking distance will be expressed in both time and distance. Change in diameter/circumference, transverse surface area and flow of the common femoral vein will be expressed in millimetres, square millimetres and millilitres per second, respectively. Furthermore change in CEAP, Villalta score, venous clinical severity score and generic and disease specific quality of life scores will be assessed. Finally, patency will be assessed. | — |
Primary
| Measure | Time frame |
|---|---|
| Main endpoint is the change in (ambulatory) venous pressure, measured at the dorsal foot vein and common femoral vein. This will be expressed in millimetres mercury. | — |
Contacts
Public ContactR.L.M. Kurstjens
Maastricht University Medical Centre+ Department of Surgery PO Box 5800
Outcome results
None listed